News | News By Subject | News by Disease News By Date | Search News

Kidney Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Comeback Kid Exelixis (EXEL) Could Pose a Huge Threat to Biotech Giants Bristol-Myers Squibb (BMY) and Pfizer (PFE)     10/18/2016
Bay Area Exelixis (EXEL)' Cabometyx Beats the Pants Off Pfizer (PFE)'s Sutent in Mid-Stage Kidney Cancer Study     10/11/2016
Comeback Kid Exelixis (EXEL)' Touts Positive Phase III Cancer Data     2/1/2016
Top 10 Best-Selling Biotech Drugs     10/2/2015
Nearly-Dead AVEO Oncology (AVEO)'s Stock Jumps on Positive European Regulatory Promises     6/5/2015
Thrasos Scores $21M to Complete Phase II THR-184, Expands Renal Portfolio     4/1/2015
EXCLUSIVE: Resverlogix Corporation (RVX.TO) CEO Says Experimental Cardiac Drug Holds High Hopes, As Biotech Booms     3/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Akebia Therapeutics, Inc. (AKBA)'s Lead Drug AKB-6548 Succeeds In Mid-Stage Trial     10/27/2014
Concert Pharmaceuticals, Inc. (CNCE) Presents Positive 48-Week Results From Phase 2 Clinical Trial Of CTP-499 In Diabetic Kidney Disease     4/28/2014
FDA Accepts Veloxis Pharmaceuticals A/S (VELO)'s New Drug Application For Envarsus®     3/14/2014
La Jolla Pharmaceutical Company (LJPC) Soars As Kidney Drug Is Effective In Phase 2 Study     3/13/2014
AMAG Pharmaceuticals, Inc. (AMAG) Drops As The FDA Turns Down Application For Iron Deficiency Drug Feraheme®     1/22/2014

News from Around the Web
Popular Acid Reflux Meds May Boost Kidney Disease Risk, Johns Hopkins University Study     10/28/2015
Teen's Nosebleed Leads To Parents' Cancer Diagnosis     7/23/2015
Tomatoes, Watermelon, And Papaya May Lower Cancer Risk In Women, Wayne State University Study     3/4/2015
Mayo Clinic Researchers Reveal Treasure Trove Of Genes Key To Kidney Cancer     7/2/2014
Mayo Clinic Researchers Say Gene In Brain Linked To Kidney Cancer     6/25/2014
Experimental Drug Prolongs Life Span In Mice, and Northwestern University and Tohoku University Study     5/5/2014
First Responders Exposed To September 11 Debris Have Damaged Kidneys, Mount Sinai School of Medicine Study     11/11/2013
New Compound Holds High Promise in Battling Kidney Cancer, University of California, Riverside Study     2/20/2013
Commonly Used Pain Pills Increase Kidney Cancer Risk in Study, Brigham and Women's Hospital Reveals     9/14/2011
Heavy Smoking Tied to Advanced Kidney Cancer, Duke University Study     5/16/2011
Agent Orange Linked to Kidney Cancer: Veterans Affairs Medical Center Study     5/16/2011
Blood Pressure May Hint at Kidney Cancer Outcome, Cleveland Clinic Study     5/6/2011
American Society of Nephrology: Lipid Combo Cuts CV Risk in Kidney Disease, Oxford University Study     11/22/2010
Mayo Clinic Researchers Find Genetic Secrets to Common Kidney Cancer     5/19/2010
Cancer Risk the Same for Kidney Transplant Recipients, No Matter the Drug, George Institute for International Health Study Finds     5/4/2010

Press Releases
Liquid Biopsy Offers A New Way To Target Kidney Cancer, City of Hope Study Suggests     2/17/2017
Xcell Biosciences Initiates New Collaborations With UCSF Researchers Studying Effectiveness Of Immunotherapy In Urologic Cancers     9/22/2016
Peloton Therapeutics Announces Dual Publications Of HIF-2a Antagonism In Kidney Cancer In The Journal Nature     9/6/2016
ASCO2016: Peloton Therapeutics Presents Clinical Data On First-In-Class Oral HIF-2a Inhibitor In Patients With Advanced Kidney Cancer At 2016 ASCO Annual Meeting     6/6/2016
PROOF Centre Collaboration Focuses On Prognostic Biomarkers For Chronic Kidney Disease     2/11/2016
Exelixis (EXEL) Announces European Medicines Agency Acceptance Of Marketing Authorization Application For Cabozantinib As A Treatment Foradvanced Renal Cell Carcinoma     1/29/2016
Rosetta Genomics Ltd. (ROSG) Granted U.S. Patent Allowance For Use Of Gene Expression Signature For Classification Of Kidney Tumors     1/25/2016
Entia Biosciences Begins Clinical Study Of Proprietary Ergod2 Medical Food Product To Demonstrate Improved Health For The More Than 25 Million Chronic Kidney Disease Sufferers In The U.S.     12/21/2015
Resverlogix (RVX.TO) Presents Important New Data At The Annual American Society of Nephrology Kidney Week Conference     11/9/2015
FibroGen, Inc. (FGEN) Release: Phase II Data For Investigational Orally Active HIF-PHI Roxadustat (FG-4592) Show Anemia Correction In Incident Dialysis Chronic Kidney Disease Patients Regardless Of Iron Repletion Status, Iron Supplementation Regimen, Or Dialysis Modality     10/23/2015
Exelixis (EXEL) Initiates Rolling Submission Of U.S. New Drug Application For Cabozantinib For The Treatment Of Advanced Kidney Cancer     10/22/2015
Shire (SHPG)'s CINRYZE Receives FDA Fast Track Designation     10/13/2015
Hutchison China MediTech (Chi-Med) Release: Savolitinib Completes Enrolment For Phase II Clinical Trial In Papillary Renal Cell Carcinoma     10/13/2015
Argos Therapeutics, Inc. (ARGS) To Host Review Of The Current Clinical Research Landscape In Kidney Cancer Following The 40th Congress Of The European Society For Medical Oncology, With Insights From Dr. Charles Drake Of Johns Hopkins Kimmel Cancer Center     10/5/2015
Pharmalink AB Raises SEK100m To Advance Nefecon Development As New Treatment For Kidney Disease     10/1/2015